IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Piramal Acquires U.S. Firm

11:05 AM MST | March 6, 2009

Indian pharmaceutical company Piramal Healthcare (Mumbai), formerly known as Nicholas Piramal, says it has completed the acquisition of Minrad International (Orchard Park, NY) for about $40 million. The deal calls for shareholders of Minrad, a producer of generics inhalation anesthetics, to receive $0.12/share. Minrad will operate as a Piramal wholly owned subsidiary. Piramal has sales of about $580 million and a portfolio including nine therapeutic areas. The company is also a custom manufacturer, with assets in Asia, Europe, and North America. The acquisition...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa